Neuroscience

New blood test for Alzheimer's developed

A new blood test for Alzheimer's disease has been developed under the leadership of researchers at the University of Gothenburg. The method is based on measuring a specific variant of tau protein in ordinary blood samples, ...

Oncology & Cancer

Prostate cancer 'fingerprint' detected in blood sample

Scientists at UCL have invented a new test to identify the earliest genetic changes of prostate cancer in blood: a process which could allow doctors to see if cancers have spread, monitor tumour behaviour and enable better ...

Alzheimer's disease & dementia

Protein misfolding as a risk marker for Alzheimer's disease

In symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer's disease—up to 14 years before a clinical diagnosis is made. Amyloid-β folding ...

Diabetes

Routine blood tests could predict diabetes

Random plasma glucose tests could be used to predict which patients will develop diabetes, according to a study of Veterans Affairs treatment data. Researchers from several VA systems showed that levels of glucose found during ...

Oncology & Cancer

Imaging agent helps predict success of lung cancer therapy

Doctors contemplating the best therapy for lung cancer patients may soon be able to predict the efficacy of a widely used lung cancer drug based on an imaging agent and a simple scan, according to the findings of a new clinical ...

Diseases, Conditions, Syndromes

Analysis of EBV DNA in plasma samples IDs nasopharyngeal CA

(HealthDay)—Analysis of Epstein-Barr virus (EBV) DNA in plasma samples can identify early asymptomatic nasopharyngeal carcinoma, according to a study published in the Aug. 10 issue of the New England Journal of Medicine.

page 1 from 4